Duke Vaccine and Trials Unit

Durham, North Carolina 27710

7 studies enrolling now · 27 studies all time

What they study most

Avian Influenza, COVID -19, COVID-19, COVID-19 Infection, COVID-19 Vaccines, Clostridioides Difficile Associated Disease, H3N2 Influenza, Healthy, Human Metapneumovirus, Human Metapneumovirus and Human Parainfluenza Infection, Influenza, Influenza Immunisation

Studies at this site

• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age — Recruiting now
• A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised — Recruiting now
• pH1N1 Blinded Challenge Study — Recruiting now
• BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies — Recruiting now
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. — Recruiting now
• A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older — Recruiting now
• A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine — Starting soon
• A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children — Completed
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants — Running, not enrolling
• A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months — Running, not enrolling
• A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes — Running, not enrolling
• A Study to Learn About How a New Pneumococcal Vaccine Works in Adults — Running, not enrolling
• A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults — Completed
• A Study About Modified RNA Vaccines Against Influenza in Healthy Adults — Completed
• A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults — Completed
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
• A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox — Completed
• A Study to Learn About How a New Pneumococcal Vaccine Works in Children — Completed
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. — Completed
• COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial) — Completed
• Flublok or Fluzone With Advax-CpG55.2 or AF03 — Completed
• Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine — Stopped early
• A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age — Completed
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology — Completed
• Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly — Completed
• Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin Level — Stopped early
• Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure — Completed